Innate Pharma SA (IPH):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Innate Pharma SA (IPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82397FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Innate Pharma SA (Innate Pharma) is a bio-pharmaceutical company. It holds expertise in the areas of immunopharmacology and antibody technology. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies that targets receptors and pathways in controlling the activation of innate immunity cells. Innate Pharma’s product portfolio includes Lirilumab, anti-KIR mAb; IPH2201, anti-NKG2A mAb; IPH4102, anti-KIR3DL2 mAb; IPH33, anti-TLR3 mAb; and IPH43, anti-MICA mab. The company has collaborations and partnerships with academic laboratories, clinical centers and industrial leaders. Some of the company’s key partners include Novo Nordisk A/S, Bristol-Myers Squibb, the Institut Gustave Roussy and the Hopital Saint Louis in Paris, and the Institut Paoli-Calmettes in Marseille, among others. Innate Pharma is headquartered in Marseille, France.

Innate Pharma SA Key Recent Developments

Nov 05, 2013: Innate Pharma announces revenue for the first nine months of 2013 and updates on its cash position
Oct 15, 2013: INNATE PHARMA: presents proprietary antibody-drug conjugate technology at the World ADC Summit in San Francisco
Oct 02, 2013: Innate Pharma appoints Nicolai Wagtmann Chief Scientific Officer
Sep 19, 2013: Innate Pharma Announces Financial results for the first half of 2013
Jul 01, 2013: Annual General Meeting of June 28, 2013

This comprehensive SWOT profile of Innate Pharma SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Innate Pharma SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Innate Pharma SA – Key Information
Innate Pharma SA – Overview
Innate Pharma SA – Key Employees
Innate Pharma SA – Key Employee Biographies
Innate Pharma SA – Key Operational Heads
Innate Pharma SA – Major Products and Services
Innate Pharma SA – History
Innate Pharma SA – Company Statement
Innate Pharma SA – Locations And Subsidiaries
Innate Pharma SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Innate Pharma SA – Business Description
Innate Pharma SA – Corporate Strategy
Innate Pharma SA – SWOT Analysis
SWOT Analysis – Overview
Innate Pharma SA – Strengths
Innate Pharma SA – Weaknesses
Innate Pharma SA – Opportunities
Innate Pharma SA – Threats
Innate Pharma SA – Key Competitors

Section 3 – Company Financial Performance Charts

Innate Pharma SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Innate Pharma SA, Key Information
Innate Pharma SA, Key Ratios
Innate Pharma SA, Share Data
Innate Pharma SA, Major Products and Services
Innate Pharma SA, History
Innate Pharma SA, Key Employees
Innate Pharma SA, Key Employee Biographies
Innate Pharma SA, Key Operational Heads
Innate Pharma SA, Other Locations
Innate Pharma SA, Subsidiaries
Innate Pharma SA, Key Manufacturing facilities
Innate Pharma SA, Key Competitors
Innate Pharma SA, SWOT Analysis
Innate Pharma SA, Ratios based on current share price
Innate Pharma SA, Annual Ratios
Innate Pharma SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Innate Pharma SA, Performance Chart
Innate Pharma SA, Ratio Charts

★海外企業調査レポート[Innate Pharma SA (IPH):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Turner Broadcasting System Inc:企業の戦略的SWOT分析
    Turner Broadcasting System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Duro Felguera, S.A.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Duro Felguera, S.A." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligen …
  • Berger Paints Jamaica Limited (BRG):企業の財務及び戦略的SWOT分析
    Summary Berger Paints Jamaica Limited (Berger Jamaica), subsidiary of Berger Paints is a chemical company that manufactures and distributes decorative paints. The company offers products that include protective coatings, architectural, wood finishes and marine paints. It also provides products such …
  • Cosmo Bio Co., Ltd. (3386):企業概要、財務及び戦略的SWOT分析
    Summary Cosmo Bio Co., Ltd. (Cosmo Bio) is a biopharmaceutical company. The company develops and markets products for diagnostic market. It provides research reagents for biochemistry, such as sugars, lipids, lectins, hormones, peptides, amino acids and chemical substances. The company’s product cat …
  • Ion Beam Applications SA (IBAB):企業のM&A・提携動向(医療機器分野)
    Summary Ion Beam Applications SA (IBA) is a medical technology company that develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses i …
  • Rolfes Holdings Limited (RLF):企業財務及び戦略的SWOT分析
    Summary Rolfes Holdings Limited (Rolfes), formerly Rolfes Technology Holdings Limited is a chemical company that operates through industrial chemicals, agricultural chemicals, and mining and water chemical divisions. The company’s industrial chemicals division offers products such as alkyd resins, v …
  • Airborne Systems, Ltd.(航空宇宙・防衛):企業概要及びSWOT分析
    Summary Strategic Defence Intelligence's "Airborne Systems, Ltd.: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, bu …
  • Sims Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sims Group Limited Mergers and …
  • Silicon Image, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Silicon Image, Inc. Mergers and …
  • Morgans Hotel Group Co:戦略・SWOT・企業財務分析
    Morgans Hotel Group Co - Strategy, SWOT and Corporate Finance Report Summary Morgans Hotel Group Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BLandH Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BLandH Co., Ltd. Mergers and Ac …
  • BioTime, Inc. (BTX):企業のM&A・提携動向(医療機器分野)
    Summary BioTime, Inc. (BioTime) is a biotechnology company with focus on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. The company is als …
  • Instacom Group Berhad (INSTACO):企業概要、財務及び戦略的SWOT分析
    Summary Instacom Group Berhad (Instacom) is a technology service provider. The company provides services such as e-business architecture, web design and content services, application design and development, business requirements study, system analysis and design and ebusiness implementation. It also …
  • Olympus America, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Olympus America, Inc. (Olympus America) is an equipment manufacturer that designs, develops and manufactures products for healthcare. The company’s medical and surgical products include system biological microscopes and inverted biological microscopes, and others. Its industrial microscope s …
  • ARC Resources Ltd. (ARX):企業のM&A・提携動向(石油・ガス分野)
    Summary ARC resources Ltd. (ARC) is a conventional oil and gas company. It carries out the exploration, development, production and sale of crude oil, natural gas and natural gas liquids (NGLS). The company also holds expertise in resource play development. ARC holds interest and conducts operations …
  • FTI Consulting, Inc. (FCN):企業の財務及び戦略的SWOT分析
    Summary FTI Consulting, Inc. (FTI) is a business advisory and consulting service provider. Its services include corporate finance and restructuring, economic consulting, forensic and litigation consulting, strategic communications and technology services among others. FTI also offers bankruptcy supp …
  • Health Discovery Corp (HDVY):企業財務及び戦略的SWOT分析
    Summary Health Discovery Corp (HDC) is a biotechnology company that offers medicine and biomarker discovery services. The company’s products comprise support vector machine, recursive feature elimination and fractal genomic modeling. It offers SVM technology that is an artificial intelligence applic …
  • United Technologies Corporation:企業のM&A・提携・投資分析
    United Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Aromasoft Corporation (072770):企業概要、財務及び戦略的SWOT分析
    Summary Aromasoft Corporation (Aromasoft) is an information technology company. The company develops and markets mobile software platform and technologies for mobile devices. Its products include mTea, aromaWIPI, eXpanon and AromaUX. Aromasoft’s mTea is a package of software solutions, which enables …
  • Afren plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Afren plc Mergers and Acquisiti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆